Novo Nordisk Sues Eli Lilly Over Misleading GLP-1 Drug Ads
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging that the US drugmaker ran deceptive advertising for its GLP-1 medications. Novo is asking the court to permanently ban the ads and order Eli Lilly to issue corrective advertising to counter the misleading claims.
Comments
No comments yet
Comments
No comments yet โ be the first to weigh in ๐
No comments yet. Be the first!